We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Rejects Pfizer's Application for Injectable Cox-2
FDA Rejects Pfizer's Application for Injectable Cox-2
September 23, 2005
Pfizer has received an FDA “non-approvable” letter for parecoxib, a non-narcotic injectable Cox-2 inhibitor already approved and marketed in the European Union (EU).